News | March 20, 2023
Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
he product will be launched shortly in the US market.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
FDA also accepts a separate supplemental application to extend prophylaxis with PREVYMIS to 200 days in certain HSCT recipients
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
Subscribe To Our Newsletter & Stay Updated
